KIF5A and lung adenocarcinoma: Kinesin family member 5A (KIF5A) inhibits lung adenocarcinoma (LUAD) cell anoikis, while the small molecule drug Ergotamine targets and inhibits the expression of KIF5A, which in turn induces LUAD cell anoikis.